Cizzle Biotechnology Holdings PLC
CIZ
Company Profile
Business description
Cizzle Biotechnology Holdings PLC is a cancer diagnostics company. It is engaged in development of test for the early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker.
Contact
c/o Ampa Holdings LLP
32 London Bridge Street
Level 19, The Shard
LondonSE1 9SG
GBRT: +44 2039346630
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2
Stocks News & Analysis
stocks
Chart of the Week: Has gold reached bear market territory?
Investors are facing a shifting landscape.
stocks
Fair value upgrade for this ASX income player
Headwinds in listed energy stocks likely to have passed
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,885.60 | 59.90 | 0.68% |
| CAC 40 | 7,974.82 | 157.88 | 2.02% |
| DAX 40 | 23,287.09 | 607.05 | 2.68% |
| Dow JONES (US) | 46,691.87 | 1,475.73 | 3.26% |
| FTSE 100 | 10,345.53 | 169.08 | 1.66% |
| HKSE | 25,294.03 | 505.89 | 2.04% |
| NASDAQ | 21,847.18 | 1,052.54 | 5.06% |
| Nikkei 225 | 53,739.68 | 2,675.96 | 5.24% |
| NZX 50 Index | 12,825.87 | 86.24 | -0.67% |
| S&P 500 | 6,581.00 | 52.48 | 0.80% |
| S&P/ASX 200 | 8,671.80 | 53.10 | 0.62% |
| SSE Composite Index | 3,948.55 | 56.69 | 1.46% |